This site is intended for healthcare professionals only
LoginRegister
Indias USD 12 billion MedTech sector set to surge to USD 20 billion by 2030: Dr Jitendra SinghIndia's USD 12 billion MedTech sector set to surge to USD 20 billion by 2030: Dr Jitendra Singh
MP Pharmacy EducationMP Pharmacy Education Crisis: Over 16,000 B.Pharm, D.Pharm Seats Vacant Amid Low Admissions
Lupin gets USFDA OAI status for Pithampur Unit 2 facilityLupin gets USFDA OAI status for Pithampur Unit 2 facility
Zydus Gets CDSCO Panel Nod to Market Sodium Chloride Nebuliser SolutionZydus Lifesciences Secures CDSCO Panel Approval for Usnoflast Capsule Interaction Study
Unichem Labs Slapped Rs 1.77 Crore NPPA Notice for Alleged Overpricing of 3 DrugsUnichem Labs Slapped Rs 1.77 Crore NPPA Notice for Alleged Overpricing of 3 Drugs
Sresan Pharmas Coldrif Syrup Banned After 48.6% Toxic Diethylene Glycol DetectedSresan Pharma's Coldrif Syrup Banned After 48.6% Toxic Diethylene Glycol Detected
CDSCO Flags MSD Pharmas Cancer Drug Trial Over Indian Representation, Control ArmCDSCO Flags MSD Pharma's Cancer Drug Trial Over Indian Representation, Control Arm
pharmacist suspendedPharmacist Suspended, New Dispensing Guidelines Issued in Rajasthan Amid Cough Syrup Row
DoP Notifies Rs 5000 Cr PRIP Scheme to Boost Pharma, MedTech R&DDoP Notifies Rs 5000 Cr PRIP Scheme to Boost Pharma, MedTech R&D
CDSCO panel nod to Bajaj Healthcare for Phase III clinical trials of Suvorexant TabletsCDSCO panel nod to Bajaj Healthcare for Phase III clinical trials of insomnia drug Suvorexant
Cough Syrup crisis: Rajasthan govt suspends drug controller, halts distribution of Kaysons Pharma medicinesCough Syrup crisis: Rajasthan govt suspends drug controller, halts distribution of Kaysons Pharma...
AstraZeneca Pharma India gains CDSCO permission for Enhertu in HER2-positive solid tumoursAstraZeneca Pharma India gains CDSCO permission for Enhertu in HER2-positive solid tumours
X